Reviewing the Effects of Chemotherapy Regimens on PFS for Patients With PSCC

Veronica Mollica, MD, continues her discussion on her recent study investigating prognostic factors and clinical outcomes in penile squamous cell carcinoma as well as highlighting the differences in PFS based on the type of chemotherapy regimen administered.

Dr. Mollica also explains her thoughts on the potential necessity of continued evaluation of prognostic factors and clinical outcomes for patients with PSCC.

Find Dr. Mollica’s previous comments here.